Alpha DNA Investment Management’s MACOM Technology Solutions MTSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-3,253
Closed -$423K – 112
2024
Q4
$423K Buy
+3,253
New +$409K 0.16% 160
2021
Q2
– Sell
-8,477
Closed -$491K – 435
2021
Q1
$491K Buy
8,477
+8,408
+12,186% +$521K 0.56% 93
2020
Q4
$3K Buy
+69
New +$2.94K ﹤0.01% 420

Other funds holding MTSI

Alpha DNA Investment Management's MTSI Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of MACOM Technology Solutions (MTSI) in Q1 2025, closing a stake of 3,253 shares — an estimated $423K sold.

Alpha DNA Investment Management first reported a position in MTSI in Q4 2020 and held it in 3 quarters. The position peaked at $491K in Q1 2021. 385 funds tracked by Wall St. Rank hold MTSI as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining MACOM Technology Solutions position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,253 MACOM Technology Solutions shares in Q1 2025, an estimated $423K.
  • Alpha DNA Investment Management first reported a position in MACOM Technology Solutions in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's MACOM Technology Solutions position peaked at $491K in Q1 2021.
  • 385 funds tracked by Wall St. Rank held MACOM Technology Solutions as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.